|
CCDC117 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33066907387547E-16 |
| Normal-vs-Stage2 |
1.77635683940025E-15 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
3.081800E-01 |
| Stage1-vs-Stage3 |
9.564100E-02 |
| Stage1-vs-Stage4 |
6.464300E-03 |
| Stage2-vs-Stage3 |
8.593400E-01 |
| Stage2-vs-Stage4 |
1.924410E-01 |
| Stage3-vs-Stage4 |
1.600760E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.92410026484447E-10 |
| Normal-vs-Asian |
1.67088565206086E-12 |
| Caucasian-vs-AfricanAmerican |
7.680200E-01 |
| Caucasian-vs-Asian |
6.977000E-01 |
| AfricanAmerican-vs-Asian |
9.986000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
5.821200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.174400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.029600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.201800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.594800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.302200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.331800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.030400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.181600E-02 |
| Classical-VS-Follicular |
2.024000E-01 |
| Classical-VS-Other |
7.984000E-01 |
| Classical-VS-Normal |
1.626032641866E-12 |
| Tall-VS-Follicular |
2.400000E-01 |
| Tall-VS-Other |
5.714200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
8.786600E-01 |
| Follicular-VS-Normal |
1.62470037423645E-12 |
| Other-VS-Normal |
1.236660E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.184170E-01 |
|
|
